181
|
|
|
NADH:ubiquinone oxidoreductase subunit B3 |
B12, CI-B12, MC1DN25 |
|
182
|
|
|
NADH:ubiquinone oxidoreductase subunit B4 |
B15, CI-B15 |
|
183
|
|
|
NADH:ubiquinone oxidoreductase subunit B7 |
B18, CI-B18, MC1DN39 |
|
184
|
|
|
NADH:ubiquinone oxidoreductase subunit B8 |
ASHI, CI-ASHI, MC1DN32 |
|
185
|
|
|
NADH:ubiquinone oxidoreductase subunit B9 |
B22, CI-B22, LYRM3, MC1DN24, UQOR22 |
|
186
|
|
|
NADH:ubiquinone oxidoreductase subunit C2 |
B14.5b, CI-B14.5b, HLC-1, MC1DN36, NADHDH2 |
|
187
|
|
|
NDUFC2-KCTD14 readthrough |
- |
|
188
|
|
|
NADH:ubiquinone oxidoreductase core subunit S1 |
CI-75Kd, CI-75k, MC1DN5, PRO1304 |
|
189
|
|
|
NADH:ubiquinone oxidoreductase core subunit S2 |
CI-49, LHONAR2, MC1DN6 |
|
190
|
|
|
NADH:ubiquinone oxidoreductase core subunit S3 |
CI-30, MC1DN8 |
Anorexia nervosa, Attention deficit hyperactivity disorder, Breast neoplasms, Hypertension, Hypothyroidism, Insomnia, Leigh syndrome, Mitochondrial complex deficiency, Optic atrophy, Diabetes mellitus type 2, Venous thromboembolism |